Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Mogamulizumab in Relapsed PTCL and CTCL
NCT01226472Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Aug 2010
- Primary completion
- Sep 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of mogamulizumab in peripheral T-cell lymphoma (PTCL), cutaneous T-cell lymphoma (CTCL), mycosis fungoides (MF), Sézary syndrome (SS), sponsored by Kyowa Kirin. Started Aug 2010; status: completed.
02
Drugs
mogamulizumab
03
Conditions
peripheral T-cell lymphoma (PTCL)cutaneous T-cell lymphoma (CTCL)mycosis fungoides (MF)Sézary syndrome (SS)
Beyond the preview
Go deeper on NCT01226472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01226472.